John M. Maraganore
2019
In 2019, John M. Maraganore earned a total compensation of $7.3M as Chief Executive Officer (principal executive officer at Alnylam Pharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $913,750 |
|---|---|
| Option Awards | $4,327,138 |
| Salary | $845,000 |
| Stock Awards | $1,204,195 |
| Other | $27,773 |
| Total | $7,317,856 |
Maraganore received $4.3M in option awards, accounting for 59% of the total pay in 2019.
Maraganore also received $913.8K in non-equity incentive plan, $845K in salary, $1.2M in stock awards and $27.8K in other compensation.
Rankings
In 2019, John M. Maraganore's compensation ranked 1,275th out of 13,971 executives tracked by ExecPay. In other words, Maraganore earned more than 90.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,275 out of 13,971 | 91st |
Division Manufacturing | 448 out of 5,701 | 92nd |
Major group Chemicals And Allied Products | 136 out of 2,200 | 94th |
Industry group Drugs | 109 out of 1,886 | 94th |
Industry Pharmaceutical Preparations | 81 out of 1,398 | 94th |
Source: SEC filing on April 2, 2021.
Maraganore's colleagues
We found five more compensation records of executives who worked with John M. Maraganore at Alnylam Pharmaceuticals in 2019.
2019
Jeffrey Poulton
Alnylam Pharmaceuticals
Chief Financial Officer
2019
Yvonne Greenstreet
Alnylam Pharmaceuticals
Chief Operating Officer
2019
Barry Greene
Alnylam Pharmaceuticals
Former President
2019
Akshay Vaishnaw
Alnylam Pharmaceuticals
President, Research and Development
2019
Laurie Keating
Alnylam Pharmaceuticals